Study #2016-0684
A Phase I/II Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
Study Status
Open
Treatment Agent
Proton Therapy
Principal Investigator
Susan L. McGovern
Description
The goal of this clinical research study is to learn if increased-dose intensity modulated proton therapy (IMPT) can help to control the disease in patients with meningioma.
General Information
Disease Group: Benign neoplasms,Malignant neoplasms of eye brain and other parts of central nervous system
Treatment Agent: Proton Therapy
Treatment Location: Both at MDACC & and Other Sites
Sponsor: Massachusetts General Hospital
Study Status
IRB Review and Approval Date: 03/31/2017
Recruitment Status: Open
Projected Accrual: 60
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Benign neoplasms,Malignant neoplasms of eye brain and other parts of central nervous system
Study phase:
Phase I/Phase II
Physician name:
Susan L. McGovern
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789